AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Legrand-Poels, S Schoonbroodt, S Piette, J
Citation: S. Legrand-poels et al., Regulation of interleukin-6 gene expression by pro-inflammatory cytokines in a colon cancer cell line, BIOCHEM J, 349, 2000, pp. 765-773

Authors: Schoonbroodt, S Ferreira, V Best-Belpomme, M Boelaert, JR Legrand-Poels, S Korner, M Piette, J
Citation: S. Schoonbroodt et al., Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress, J IMMUNOL, 164(8), 2000, pp. 4292-4300

Authors: Schoonbroodt, S Piette, J
Citation: S. Schoonbroodt et J. Piette, Oxidative stress interference with the nuclear factor-kappa B activation pathways, BIOCH PHARM, 60(8), 2000, pp. 1075-1083

Authors: Piret, B Schoonbroodt, S Piette, J
Citation: B. Piret et al., The ATM protein is required for sustained activation of NF-kappa B following DNA damage, ONCOGENE, 18(13), 1999, pp. 2261-2271

Authors: Bonizzi, G Piette, J Schoonbroodt, S Greimers, R Havard, L Merville, MP Bours, V
Citation: G. Bonizzi et al., Reactive oxygen intermediate-dependent NF-kappa B activation by interleukin-1 beta requires 5-lipoxygenase or NADPH oxidase activity, MOL CELL B, 19(3), 1999, pp. 1950-1960

Authors: Bonizzi, G Piette, J Schoonbroodt, S Merville, MP Bours, V
Citation: G. Bonizzi et al., Role of the protein kinase C lambda/iota isoform in nuclear factor-kappa Bactivation by interleukin-1 beta or tumor necrosis factor-alpha: Cell typespecificities, BIOCH PHARM, 57(6), 1999, pp. 713-720
Risultati: 1-6 |